H&T Presspart is pleased to announce its participation as a Platinum Sponsor of Exploring the Future of Inhalation Drug Delivery 2026, taking place in Parma, Italy, from 8–10 September 2026.

As one of the leading events dedicated to the future of inhalation science, respiratory therapies and drug delivery technologies, the conference brings together experts from across the pharmaceutical, device development and manufacturing sectors to explore the innovations shaping tomorrow’s inhalation products.

As part of our Platinum Sponsorship, H&T Presspart will be exhibiting throughout the event and sharing our expertise through a featured conference presentation from Dr. Anselm Ebert entitled:  “Navigating Inhalation Trends: Delivering Innovative, Sustainable Device Solutions”

Delegates visiting the H&T Presspart exhibition stand will have the opportunity to explore our latest inhalation device innovations and discuss development challenges with our experts. Featured technologies will include our Sunriser® dry powder inhaler technology alongside our expanding capabilities supporting the transition to low-GWP propellant pMDIs.

From analytical testing and development support through to pMDI filling for next-generation propellants, H&T Presspart provides an integrated solution to help pharmaceutical partners navigate this important industry shift.

If you are attending the show and would like to arrange a meeting please contact the team.